- Home
- VNDA vs LAW Comparison
VNDA vs LAW Comparison
Compare VNDA & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- LAW
- Stock Information
- Founded
- VNDA 2002
- LAW 2013
- Country
- VNDA United States
- LAW United States
- Employees
- VNDA N/A
- LAW N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- LAW Computer Software: Prepackaged Software
- Sector
- VNDA Health Care
- LAW Technology
- Exchange
- VNDA Nasdaq
- LAW Nasdaq
- Market Cap
- VNDA 237.9M
- LAW 209.5M
- IPO Year
- VNDA 2006
- LAW 2021
- Fundamental
- Price
- VNDA $3.95
- LAW $3.99
- Analyst Decision
- VNDA Strong Buy
- LAW Hold
- Analyst Count
- VNDA 2
- LAW 3
- Target Price
- VNDA $16.50
- LAW $6.17
- AVG Volume (30 Days)
- VNDA 471.1K
- LAW 76.2K
- Earning Date
- VNDA 05-07-2025
- LAW 05-07-2025
- Dividend Yield
- VNDA N/A
- LAW N/A
- EPS Growth
- VNDA N/A
- LAW N/A
- EPS
- VNDA N/A
- LAW N/A
- Revenue
- VNDA $201,351,000.00
- LAW $145,923,000.00
- Revenue This Year
- VNDA $14.36
- LAW $5.10
- Revenue Next Year
- VNDA $44.53
- LAW $5.18
- P/E Ratio
- VNDA N/A
- LAW N/A
- Revenue Growth
- VNDA 13.37
- LAW 3.84
- 52 Week Low
- VNDA $3.85
- LAW $3.31
- 52 Week High
- VNDA $6.75
- LAW $8.20
- Technical
- Relative Strength Index (RSI)
- VNDA 33.16
- LAW 57.88
- Support Level
- VNDA $4.20
- LAW $3.49
- Resistance Level
- VNDA $4.51
- LAW $3.84
- Average True Range (ATR)
- VNDA 0.18
- LAW 0.15
- MACD
- VNDA -0.02
- LAW 0.07
- Stochastic Oscillator
- VNDA 1.43
- LAW 94.35
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.